Multimodal treatment of drug-induced gingival hyperplasia in a kidney transplant patient.
Medical advances for treating organ diseases have resulted in thousands of organ transplants being performed each year. Every patient receiving a transplanted organ will also be placed on drugs that may induce gingival hyperplasia as a side effect. This article discusses the multiphasic approach to treating the disfiguring hyperplasia through chemical and mechanical plaque control, surgical removal of the tissue by lasers, and postsurgical rinses with folate.
Rossmann
J A
JA
Department of Stomatology, University of Texas-Houston, Health Science Center, Dental Branch.
Ingles
E
E
Brown
R S
RS
D000328:Adult; D002710:Chlorhexidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects*; D017742:Dental Care for Chronically Ill / Q000379:methods*; D003773:Dental Plaque / Q000517:prevention & control; D004347:Drug Interactions; D005492:Folic Acid / Q000627:therapeutic use; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000601:surgery / Q000628:therapy*; D005890:Gingivectomy / Q000379:methods; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects; D053685:Laser Therapy; D008297:Male; D009543:Nifedipine / Q000009:adverse effects*; D010347:Patient Care Planning
D016572:Cyclosporine; D005492:Folic Acid; D009543:Nifedipine; C010882:chlorhexidine gluconate; D002710:Chlorhexidine